Friday, January 29, 2021 9:23:10 AM
Draw your own conclusions. I am not in their shoes, do not see the emails and do not go to their meetings.
12/16/20220 joe Manko Director 10K shares $5.70
12/09/20220 D. Pettigrew CEO 1K shares $5.07
12/8/20220 joe Manko Director 10K shares $5.43
12/07/20220 D Goldberger Director .5K shares $5.54
12/07/20220 K. Fisher CFO .5K shares $5.3
12/03/20220 K. Fisher CFO .25K shares $5.3
11/30/20220 joe Manko Director 10K shares $4.55
11/30/20220 j Fletcher board chairman 21K shares $4.48
11/25/20220 D Goldberger Director .5K shares $4.63
**i tried to be accurate but I might have missed an insider activity.
Manuel Marques, Chief operating officer and board member sold 27K shares at $5.53 and it looks like he then exercised options to buy 62.5K shares at $.5 and exercised options to buy 75K shares at $1.57. All of this activity happened on 12/12/2020.
Recent KRMD News
- KORU Medical Systems to Participate in the 8th Annual Lake Street Best Ideas Growth Conference • Business Wire • 09/05/2024 11:00:00 AM
- KORU Medical Systems, Inc. Announces 2024 Q2 Financial Results, a Record Quarter With 22% Revenue Growth; Raises Full Year 2024 Guidance • Business Wire • 08/07/2024 08:05:00 PM
- KORU Medical Systems to Participate in the Canaccord Genuity 44th Annual Growth Conference • Business Wire • 07/25/2024 08:05:00 PM
- KORU Medical Systems, Inc Announces Leadership Changes to Support Growth Agenda • Business Wire • 07/24/2024 08:05:00 PM
- KORU Medical Systems to Report Second Quarter 2024 Financial Results on August 7, 2024 • Business Wire • 07/17/2024 08:05:00 PM
- KORU Medical Systems Receives Regulatory Clearance for FreedomEdge® Infusion System in Japan • Business Wire • 07/02/2024 11:00:00 AM
- Simplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion • Business Wire • 06/05/2024 01:00:00 PM
- KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology Biologic • Business Wire • 06/04/2024 08:03:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 09:19:50 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 05/23/2024 11:00:28 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 09:06:19 PM
- KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic • Business Wire • 05/14/2024 08:05:00 PM
- KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth • Business Wire • 05/01/2024 08:05:00 PM
- KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024 • Business Wire • 04/17/2024 11:00:00 AM
- KORU Medical Systems Announces Successful Appeal in EU Notified Body Review • Business Wire • 04/11/2024 08:05:00 PM
- KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference • Business Wire • 03/18/2024 09:24:00 PM
- KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance • Business Wire • 03/13/2024 08:05:00 PM
- KORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized Biologic • Business Wire • 03/11/2024 08:05:00 PM
- KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin • Business Wire • 03/06/2024 12:00:00 PM
- KORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024 • Business Wire • 02/21/2024 12:00:00 PM
- KORU Medical Systems to Participate in Piper Sandler’s 35th Annual Healthcare Conference • Business Wire • 11/29/2023 12:00:00 PM
- KORU Medical Systems, Inc. to Host Investor Day on December 5, 2023 • Business Wire • 11/28/2023 01:00:00 PM
- KORU Medical Systems, Inc. Announces Development Agreement for Next-generation Subcutaneous Immunoglobulin Infusion System • Business Wire • 11/08/2023 09:10:00 PM
- KORU Medical Systems, Inc. Appoints Ken Miller as Chief Commercial Officer • Business Wire • 11/08/2023 09:08:00 PM
- KORU Medical Systems, Inc. Announces 2023 Third Quarter Financial Results and Updates Full Year 2023 Outlook • Business Wire • 11/08/2023 09:05:00 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM